Announcement of the 19th JIHS Global Infectious Diseases Forum
Theme: Facing Microorganisms that Cause Cancer －Opening New Horizons
In April 2025, the National Center for Global Health and Medicine (NCGM) merged with the National Institute of Infectious Diseases to form the Japan Institute of Health Security (JIHS). Following this transition, the forum was renamed and relaunched as the JIHS Global Infectious Diseases Forum (GIDF) .The 19th GIDF, we will explore microorganisms that cause cancer, highlighting the latest findings on cancer related to infectious diseases. Furthermore, by addressing the medical environment and challenges in Southeast Asia, the forum aims to spur interest in the developing new preventives, diagnostics, and therapeutics, as well as global clinical studies/trials, including approved products.
We look forward to your participation.
- ・Date and time: Friday, January 16, 2026. 15:00-17:30 (JST)
- ・Event format: Hybrid (onsite + online), simultaneous interpretation (English- Japanese)
Venue: Nihonbashi Hall Max. 100 participants
（9th floor of Nihonbashi Takashimaya Mitsui Building. 5-1, Nihonbashi 2-chome, Chuo-ku, Tokyo）
＊For attendees participating at the venue, a casual networking reception will be held following the forum.
Online: Zoom
＊A viewing link will be sent to your registered email address by the day before the event. - ・Sponsor: Japan Agency for Medical Research and Development (AMED)
- ・Participation fee: Free of charge
- ・Registration: Pre-registration required. Please register here
- ・Registration Deadline: Friday, January 9, 2026
Program
Opening Remarks Dr. Norihiro Kokudo（President, JIHS, Japan）
Report: ARISE Latest Activities and Future Perspective
Dr. Muchanga Sifa Marie Joelle（Chief Researcher, Department of International Trials, Center for Clinical Sciences, JIHS, Japan）
Chair：Dr. Wataru Sugiura (Director, Center for Clinical Sciences, JIHS, Japan)
Lecture 1: Cervical Cancer Prevention Program in Indonesia: Effectiveness, Future Prospects and R&D Need
Dr. Tofan Widya Utami（Associate Professor, Cipto Mangunkusumo Hospital, Indonesia）
Chair：Dr. Kenichi Nakamura（Director, Department of International Clinical Development, National Cancer Center Hospital, Japan）
Lecture 2: Colon Carcinogenesis by the Colibactin Toxin Derived from the Intestinal Microbiome
Dr. Tatsuhiro Shibata（Professor, Laboratory of Molecular Medicine, The Institute of Medical Science, The University of Tokyo, Japan）
Chair：Dr. Takaji Wakita (Vice President, JIHS, Japan)
Lecture 3: Prevention and Treatment of HCC in Patients with Chronic HBV Infection
Prof. Jia-Horng Kao (National Chair Professor, National Taiwan University Hospital, Taiwan)
Closing Remarks Dr. Hideyo Miyazaki（Hospital Director, National Center for Global Health and Medicine, JIHS, Japan）
Flyer here
Contact
Secretariat of JIHS Global Infectious Diseases Forum
Department of International Trials, Center for Clinical Sciences,
Japan Institute for Health Security
1-21-1 Toyama Shinjuku-ku Tokyo, 162-8655 Japan
Email：jihs-gidf@piic-inc.com
About the Global Infectious Diseases Forum
Overview of the Forum
NCGM International Infectious Diseases Forum changed its name to JIHS Global Infectious Diseases Forum in April 2025, coinciding with the establishment of the Japan Institute of Health Security (JIHS; formed by the merger of National Center for Global Health and Medicine and National Institute of Infectious Diseases). We will continue to promote international development through public-private-academia collaboration, mainly in the field of infectious diseases. Experts provide the latest information and exchange opinions among relevant parties such as companies, medical and research institutions. We support the development of pharmaceuticals and medical devices for prevention, diagnosis, treatment as well as clinical research utilizing the international collaborative clinical research platform established by JIHS and the international clinical trial network, ARO Alliance for Southeast & East Asia (ARISE).
Content of the Forum
- ・Latest trends in infectious diseases in Japan and overseas
- ・Latest findings and countermeasures for infectious diseases such as AMR
- ・Academic information on new medical technologies and pharmaceuticals
- ・Domestic medical administration and overseas regulations
- ・Case reports on overseas clinical research and trial
- ・Introduction of JIHS's international projects and research, etc.
Past Forums
- Feb 6, 2025
18th IIDF Emerging and Imported Infectious Disease ‒ New Clinical Research Challenges in the ARISE Network ‒ - Sep 5, 2024
17th IIDF The Forefront of Diagnosis & Treatment of Viral Hepatitis, and Future Prospects - Sep 29, 2023
16th IIDF Updates on AMR - Trends and Countermeasures for Antimicrobial-resistant Bacterial Infections, and New Antibiotics - Jan 17, 2023
15th IIDF Infectious Diseases Updates - Prevention to Treatment - Jun 17, 2022
14th IIDF From Japan to overseas - International Activities of Japanese Academia and Pharmaceuticals and Medical Devices - Dec 13, 2021
13th IIDF Pharmaceutical R&D through International Cooperation in the field of SARS CoV-2 Infectious Diseases - Jun 07, 2021
12th IIDF Japanese Technology in SARS CoV-2 Infection - Jan 29, 2021
11th IIDF Past, Present and Future of the R and D in Infectious Diseases Arena - Nov 3, 2020
10th IIDF Go Global - For a Global Clinical Study Platform Bridging Japan and Asia for COVID-19 - - Mar 10, 2020→Cancelled
9th IIDF - Dec 13, 2019
8th IIDF Global Health Issue: Vaccines for Preventable Diseases - Oct 8, 2019
7th IIDF Global Health Issue: AMR Control - Jun 7, 2019
6th IIDF Access to Unmet Needs, Information and Regulatory - Mar 11, 2019
5th IIDF - Dec 21, 2018
4th IIDF Expansion of Clinical Trials in Asian Region - Oct 4, 2018
3rd IIDF Recent Trends of Infectious Diseases in the Asian Region - Jul 20, 2018
2nd IIDF Overview of Global Clinical Research Network Bases Project - Mar 7, 2018
1st IIDF
